tradingkey.logo

Lexeo Therapeutics Inc <LXEO.OQ> expected to post a loss of 78 cents a share - Earnings Preview

ReutersMay 7, 2025 12:53 PM
  • Lexeo Therapeutics Inc LXEO.OQ LXEO.O is expected to show no change in quarterly revenue when it reports results on May 9 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Lexeo Therapeutics Inc is for a loss of 78 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Lexeo Therapeutics Inc is $21.00​, above​ its last closing price of $3.25. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.81

-0.78

Beat

3.4

Sep. 30 2024

-0.66

-0.68

-0.89

Missed

-31.2

Jun. 30 2024

-0.65

-0.69

-0.64

Beat

7.4​

Mar. 31 2024

-0.76

-0.77

-0.77

Met

-0.3

​​Dec. 31 2023

-0.73

-0.73

-0.85

Missed

-16.8

Sep. 30 2023

-2.60

-2.60

-12.36

Missed

-375.8​

This summary was machine generated May 7 at 12:53 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI